ONEQ logo

ONEQ
Fidelity Nasdaq Composite Index ETF

886
Volume
4,913.00
52W High
$94.49
52W Low
$58.12
50D MA
$89.21
Prev Close
$84.91
Loading...
Loading...
News
all
press releases
CYCN Stock Is Soaring 150% Pre-Market Today — What Is Fueling The Rally?
Cyclerion stated that it has entered into a definitive merger agreement for an all-stock transaction.
Stocktwits·2h ago
News Placeholder
More News
News Placeholder
Should Fidelity Nasdaq Composite Index ETF (ONEQ) Be on Your Investing Radar?
Style Box ETF report for ONEQ
Zacks·16d ago
News Placeholder
SMX Shares Rallied Over 129% Today — Here’s Why
SMX (Security Matters) said on Friday that it has extended its capital runway into 2028.
Stocktwits·2mo ago
News Placeholder
BTOG Stock Tanks Over 30% — What Drove Shares To A Nearly Nine-Month Low?
The crypto mining firm’s board approved a 1-for-60 reverse stock split of both its Class A and Class B shares in order to maintain compliance with Nasdaq’s listing requirements.
Stocktwits·3mo ago
News Placeholder
Why Did BCTX Stock Surge 50% Today?
The biotechnology company announced a complete recovery of a lung metastasis in a patient with metastatic breast cancer treated with its Bria-OTS immunotherapy.
Stocktwits·3mo ago
News Placeholder
Should Fidelity Nasdaq Composite Index ETF (ONEQ) Be on Your Investing Radar?
Style Box ETF report for ONEQ
Zacks·3mo ago
News Placeholder
SMX Shares Double On Plastic Cycle Token Optimism — How Much More Upside Does Retail See?
Some retail traders expect SMX (Security Matters) share price to surge back up to $490 levels.
Stocktwits·3mo ago
News Placeholder
Soft Inflation Ushers Santa Onto Wall Street — Will Seasonal Trends Follow?
Inflation eased, and yields fell, lifting stocks, but stretched valuations and cautious retail sentiment temper optimism.
Stocktwits·3mo ago
News Placeholder
YD Bio Stock Rises On Entry Into US Eye Care Segment
The Taiwan-based company said that Exovisse Contact Lenses have obtained the U.S. Food and Drug Administration’s clearance through its partner 3D Global Biotech.
Stocktwits·4mo ago
News Placeholder
Jim Cramer Can’t Believe Nebius’ Capital Destruction As Stock Trades Deep In Bear Zone: ‘Pain Is Not Over’
Nebius stock is up over 200% despite the recent volatility, but it has shed 40% since its October highs.
Stocktwits·4mo ago
<
1
2
...
>

Latest ONEQ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.